Publications in collaboration with researchers from Karolinska Institute (27)

2024

  1. Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO

    Pediatric Allergy and Immunology, Vol. 35, Núm. 4

2023

  1. Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study

    Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 56

  2. Real-world evidence in achondroplasia: considerations for a standardized data set

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2020

  1. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 8, pp. 2592-2599.e3

2018

  1. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227

2017

  1. Addressing unmet needs in understanding asthma mechanisms

    European Respiratory Journal, Vol. 49, Núm. 5

  2. Asthma research in Europe: A transformative agenda for innovation and competitiveness

    European Respiratory Journal, Vol. 49, Núm. 5

2016

  1. Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument

    Clinical and Experimental Allergy

  2. Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability

    American Journal of Human Genetics, Vol. 98, Núm. 2, pp. 363-372

2014

  1. Birthweight and the risk of atopic diseases: The ISAAC Phase III study

    Pediatric Allergy and Immunology, Vol. 25, Núm. 3, pp. 264-270

  2. Classification and pharmacological treatment of preschool wheezing: Changes since 2008

    European Respiratory Journal

2013

  1. The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three

    Clinical and Experimental Allergy, Vol. 43, Núm. 1, pp. 73-84

2012

  1. The challenges of replicating the methodology between Phases I and III of the ISAAC programme

    International Journal of Tuberculosis and Lung Disease, Vol. 16, Núm. 5, pp. 687-693

2011

  1. Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International study of asthma and allergies in childhood phase three

    American Journal of Respiratory and Critical Care Medicine, Vol. 183, Núm. 2, pp. 171-178

  2. Global analysis of breast feeding and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6-7 year old children: ISAAC Phase Three

    Allergologia et Immunopathologia, Vol. 39, Núm. 6, pp. 318-325

  3. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease

    Orphanet Journal of Rare Diseases, Vol. 6, Núm. 1

2010

  1. International variations in bronchial responsiveness in children: Findings from ISAAC phase two

    Pediatric Pulmonology, Vol. 45, Núm. 8, pp. 796-806

  2. The impact of the method of consent on response rates in the ISAAC time trends study

    International Journal of Tuberculosis and Lung Disease, Vol. 14, Núm. 8, pp. 1059-1065

  3. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One

    Respiratory Research, Vol. 11